AI in Drug Discovery Fundamental Analysis

Table of Contents

Excel Deliverables

1. KEY PLAYERS AND PRODUCTS DATASET
1.1. Analysis Notes
1.2. Summary Dashboard
1.3. Market Landscape Dataset
1.4. Product Landscape Dataset
1.5. Company Health Indexing
1.6. Value Proposition Analysis
1.7. Key Acquisition Targets
 A1 – A8Appendices

2. FUNDING AND INVESTMENT ANALYSIS
2.1. Analysis Notes
2.2. Summary Dashboard
2.3. Capital Investments in AI-based Drug Discovery
 A1 – A2Appendices

3. POTENTIAL INVESTMENT OPPORTUNITIES
3.1. Market Forecast (Input Data)
3.2. Leading Business Segments
3.3. Optimal Investment Targets

4. FUNDAMENTAL AND TECHNICAL FINANCIAL ANALYSIS
The information presented in this analysis is spread across separate MS Excel sheets, which provide information on key financial parameters and competitive insights based on historical and prevalent trends.

5. BUSINESS RISK ANALYSIS
5.1. Analysis Notes
5.2. Business Risk Data
 A1 – A2Appendices

6. MARKET FORECAST AND OPPORTUNITY ANALYSIS 
6.1. Analysis Notes
6.2. Summary Dashboard
6.3. Market Forecast and Opportunity Analysis
 A1 – A2Appendices

7. RETURNS ON INVESTMENT 
7.1. Analysis Notes
7.2. Estimated RoI for Investors in Company A
7.3. Estimated RoI for Investors in Company B
7.4. Estimated RoI for Investors in Company C
7.5. Estimated RoI for Investors in Company D
7.6. Estimated RoI for Investors in Company E
7.7. Estimated RoI for Investors in Company F
7.8. Estimated RoI for Investors in Company G
7.9. Estimated RoI for Investors in Company H
7.10. Estimated RoI for Investors in Company I
7.11. Estimated RoI for Investors in Company J
 A1 – A2Appendices

PowerPoint Deliverables

1. Context  

2. Project Approach  

3. Project Objectives

4. Executive Summary

Section I: Need for AI-based Drug Discovery Market and Market Landscape

5.  AI-BASED DRUG DISCOVERY MARKET
5.1. Overview
5.2. Types of AI
5.3. Developmental History
5.4. Key Players
5.5. Benefits of AI in Drug Discovery
5.6. Challenges Related to AI in Drug Discovery
5.7. Contemporary Sentiments and Expert Opinions

6. Market Landscape
6.1. Key Players in the AI in Drug Discovery Market
6.2. Analysis of Competitive Landscape 
6.3. Conclusion

7. Product Landscape and Company Health Indexing
7.1. List of Products 
7.2. Analysis of Product Landscape 
7.3. Health Indexing Methodology
7.4. Company Health Indexing

8. Value Proposition Analysis
8.1. Overview and Methodology
8.2. Intellectual Capital Related Value
8.3. Developer Value 
8.4. Platform Related Value
8.5. Value to End User
8.6. Conclusion

9. Company Competitiveness Analysis
9.1. Overview and Methodology
9.2. Company Competitiveness Analysis
9.3. Concluding Remarks

Section II Analysis of Investments

10. Funding and Investments Analysis
10.1. Overview
10.2. Analysis by Type of Funding
10.3. Analysis by Geography
10.4. Most Active Players and Popular Investors
10.5. Analysis of Trends Associated with Individual Funding Categories
10.6. Funding and Investments Summary

Section III Financial Analysis and Assessment of Business Risks

11. Financial Analysis of Public Ventures
11.1. Fundamental Financial Analysis Overview
11.2. Financial Ratios (Interpretation Guide)
11.3. Case Study 1
11.4. Technical Financial Analysis Overview
11.5. Technical Indicators (Interpretation Guide)
11.6. Case Study 2
11.7. Company Profiles

12. Business Risk Analysis 
12.1. Overview and Methodology
12.2. Operations-related Risks
12.3. Business-related Risks
12.4. Financial / Asset-related Risks
12.5. Product / Technology Risks
12.6. Other Risks
12.8. Business Risks Summary

Section IV Market Forecast and Opportunity Analysis

13. Market Forecast and Opportunity Analysis
13.1. Overview and Methodology
13.2. Global AI in Drug Discovery Market, 2022 - 2035
13.2.1. Analysis by Drug Discovery Steps
13.2.2. Analysis by Geography
13.2.3. Analysis by Therapeutic Area
13.2.4. Concluding Remarks

Section V Analysis of Returns on Investment, Key Acquisition Targets and Promising Investment Opportunities

14. Analysis of Returns on Investment
14.1. Overview and Methodology 
14.2. Case Studies
14.3. Concluding Remarks

15. Key Acquisition Targets
15.1. Overview
15.2. List of Key Acquisition Targets
15.3. Concluding Remarks

16. Promising Investments Analysis
16.1. Overview and Methodology
16.2. Leading Business Segments 
16.3. Concluding Remarks

17. Conclusion

18. Appendices

List of Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report.

1. 3BIGS
2. 99andBeyond
3. A2A Pharmaceuticals
4. A2i Therapeutics
5. AbCellera
6. Absci
7. Accutar Biotech
8. Acellera
9. AcuraStem
10. Adagene
11. Aganitha 
12. AI Therapeutics
13. AI VIVO
14. Ai-biopharma
15. Aiforia
16. Aigenpulse
17. Ainnocence
18. Alphanosos
19. Anagenex
20. Anima Biotech
21. Antiverse
22. ApexQubit
23. Aqemia
24. Arctoris
25. Ardigen
26. Aria Pharmaceuticals
27. Arpeggio Biosciences
28. Arzeda
29. Atavistik Bio
30. Atomwise
31. Auransa
32. BenevolentAI
33. BERG
34. BigHat Biosciences
35. BioAge Labs
36. Biolojic Design
37. Biorelate
38. BioSymetrics
39. bioSyntagma
40. biotx.ai
41. CardiaTec Biosciences
42. Causaly
43. Cellarity
44. Celsius Therapeutics
45. CHARM Therapeutics
46. ChemAlive
47. ChemPass
48. Cloud Pharmaceuticals
49. Collaborations Pharmaceuticals
50. Collective Scientific 
51. Cortex Discovery
52. Cyclica
53. CytoReason
54. Data2Discovery
55. Data4Cure
56. Deargen
57. Deep Genomics
58. DeepMatter
59. DeepCure
60. Deepflare
61. DeepTrait
62. Denovicon Therapeutics
63. DevsHealth
64. DEXSTR
65. Differentiated Therapeutics
66. Dyno Therapeutics
67. Elucidata
68. Empirico
69. Engine Biosciences
70. Enveda Biosciences
71. Envisagenics
72. Epicombi Therapeutics
73. Erasca
74. Euretos
75. Evariste Technologies
76. Evaxion Biotech
77. Excelra
78. Exscientia
79. Fountain Therapeutics
80. Frontier Medicines
81. G3 Therapeutics
82. Gatehouse Bio
83. Genesis Therapeutics
84. Genialis
85. Genome Biologics
86. Genuity Science
87. Gero
88. Gordian Biotechnology
89. Gritstone bio
90. Hafnium Labs
91. Health Technology Innovations
92. Healx
93. Herophilus
94. Hinge Therapeutics
95. HLTH
96. HotSpot Therapeutics
97. Humonic
98. Ichor Biologics
99. Iktos
100. IMIDomics
101. Immunocure Discovery Solutions
102. Innophore
103. Innoplexus
104. inSili.com
105. InsilianceInsilico Medicine
106. Insitro
107. Intellegens
108. Intelligent OMICS
109. Interline Therapeutics
110. Invea Therapeutics
111. InveniAI
112. Isomorphic Labs
113. JADBio
114. Juvena Therapeutics
115. Keen Eye
116. ksilink
117. Kuano
118. LabGenius
119. Lantern Pharma
120. MAbSilico
121. Medchemica
122. Medirita
123. Menten AI
124. METiS Therapeutics
125. Micar Innovation
126. Model Medicines (previously known as Receptor.AI)
127. Molecule.one
128. Moleculomics
129. Molomics Biotech (Acquired by VeriSIM Life)
130. Nanna Therapeutics (a wholly owned subsidiary of Astellas)
131. Netabolics
132. NineteenGale Therapeutics
133. Notable Labs
134. Nucleai
135. Numedii
136. Nuritas
137. OccamzRazor
138. Olaris
139. OneThree Biotech
140. Optibrium
141. Owkin
142. Oxford Drug Design
143. PEACCEL
144. Pending AI
145. Pepticom
146. Peptone
147. Peptris Technologies
148. PercayAI
149. Pharmacelera
150. PharmCADD
151. PharmEnable
152. Pharnext
153. Pharos iBio
154. Phenomic AI
155. Plex Research
156. Polaris Quantum Biotech
157. PostEra
158. PrecisionLife
159. Protai
160. ProteinQure
161. ProteiQ Biosciences
162. RECEPTOR.AI AI
163. Recursion Pharmaceuticals
164. Relation Therapeutics
165. Relay Therapeutics
166. Remedium AI
167. Resonant Therapeutics
168. Reverie Labs
169. ReviveMed
170. Saverna Therapeutics
171. SEngine Precision Medicine
172. Sensyne Health
173. Sentauri
174. Shuimu BioSciences
175. Sinopia Biosciences
176. Sirenas
177. SOCIUM
178. Soley Therapeutics
179. SOM Biotech
180. SparkBeyond
181. Spektron Systems
182. Spring Discovery
183. Sravathi AI
184. Standigm
185. Structura Biotechnology
186. SYNSIGHT
187. Syntekabio
188. SYSTEMS ONCOLOGY
189. Terray Therapeutics
190. TeselaGen Biotechnology
191. Transilico
192. Transition Bio
193. Turbine Simulated Cell Technologies
194. Unnatural Products
195. Valence Discovery (Formerly known as InVivo AI)
196. Valo
197. VantAI
198. Verge Genomics
199. VeriSIM
200. Vingyani
201. Wisecube
202. X-37
203. Xbiome
204. XtalPi
205. Zymergen

Source 1: https://www.sciencedirect.com/science/article/pii/S2211383522000521
Source 2: http://phrma-docs.phrma.org/sites/default/files/pdf/rd_brochure_022307.pdf